Strictureplasty for Treatment of Crohn's Disease: an ACS-NSQIP Database Analysis JOURNAL OF GASTROINTESTINAL SURGERY Geltzeiler, C. B., Young, J. I., Diggs, B. S., Keyashian, K., Deveney, K., Lu, K. C., Tsikitis, V. L., Herzig, D. O. 2015; 19 (5): 905-910

Abstract

Strictureplasty is an alternative to resection for treatment of Crohn's disease (CD) strictures. It preserves bowel length, and specialized centers report favorable outcomes. Strictureplasty rates, however, are thought to be low, and it was recently removed from required cases for colon and rectal surgery residents. We examined operative characteristics, and trends in its use using a large national database.We examined the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database from 2005 to 2012, identifying patients with CD who underwent strictureplasty. We identified patient characteristics, outcome variables, and trends in utilization of strictureplasty.A total of 9172 patients underwent surgery for CD. Two hundred fifty-six (2.8 %) underwent strictureplasty. Median preoperative albumin was 3.6. Preoperative steroid use and weight loss rates were 39 and 8 %. Rates of wound infection and organ space infection were 11 and 4 %. Rate of reoperation was 6 %. Outcomes did not change significantly over time (all p?=?NS). The proportion of CD operations that included a strictureplasty decreased from 5.1 to 1.7 % (OR 0.902 with each additional year, 95 % CI (0.852, 0.960), p?

View details for DOI 10.1007/s11605-015-2749-8

View details for Web of Science ID 000353198400014

View details for PubMedID 25617078